Risk factors for acne development in the first 2 years after initiating masculinizing testosterone therapy among transgender men

J Am Acad Dermatol. 2019 Aug;81(2):617-618. doi: 10.1016/j.jaad.2018.12.040. Epub 2019 Jan 31.

Authors

Jason Andrew Park¹, Erin Elizabeth Carter¹, Allison Ruth Larson²

Affiliations

¹ Boston University School of Medicine, Boston, Massachusetts.
² Boston University School of Medicine, Boston, Massachusetts; Department of Dermatology, Boston Medical Center, Boston, Massachusetts. Electronic address: arlarson@bu.edu.

PMID: 30711356
DOI: 10.1016/j.jaad.2018.12.040

No abstract available

Publication types

Letter

MeSH terms

Acne Vulgaris / blood
Acne Vulgaris / epidemiology*
Adolescent
Adult
Body Mass Index
Boston / epidemiology
Female
Humans
Male
Risk Factors
Sex Reassignment Procedures
Smoking / epidemiology
Testosterone / blood
Testosterone / therapeutic use*
Transgender Persons*
Young Adult

Substances

Testosterone